Navigation Links
Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Results; Provides 2008 Outlook
Date:2/20/2008

20,710 10,731 79,073 10,731

Gross margin 14.4% 11.6% 14.0% 11.6%

Selling and marketing 12,777 8,409 52,023 8,409

Segment contribution $7,933 $2,322 $27,050 $2,322

Segment margin 5.5% 2.5% 4.8% 2.5%

* Represents two months of operations in 2006 following the acquisition

of Andrx.

Distribution segment net revenue for the fourth quarter of 2007 was $144.1 million, an increase of 11 percent from $129.9 million reported in the third quarter 2007. The increase was due primarily to the distribution of new products launched by generic companies, including the launch of a generic version of Wyeth's Protonix(R).

Gross margin for the Distribution segment increased from 13 percent in the third quarter 2007 to 14 percent in the fourth quarter 2007, reflecting an improved product mix.

For the full year 2007, Distribution segment net revenue was $566.1 million and segment gross margin for the full year was 14 percent.

2008 Financial Outlook

Watson's estimates are based on the Company's actual results for 2007, and management's current belief about prescription trends, pricing levels, inventory levels and the anticipated timing of future product launches and events.

Watson estimates total net revenue for the full year of 2008 at approximately $2.5 billion.

Net Revenue Estimates by Segment

For the Twelve Months Ending December 31, 2008

Generic Segment $1.45 - $1.55 Billion

Brand Segment $420 - $440 Million

Distribution Segment $580 - $610 Million

Research and development investment for 2008 is expected to be $160 to $170 million. Selling, general and administrative expenses for 2008 are expected to be $420 to
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Watson to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
2. Warner Chilcott and Watson Pharmaceuticals Announce Launch of Tilia(TM) Fe
3. Watson Receives FDA Approval for Generic Accuneb(R)
4. Watson to Present at the Bear Stearns 20th Annual Healthcare Conference
5. Graceway Pharmaceuticals, LLC(TM) Announces Completed Acquisition of All Assets Related to Estrasorb(R) Product Line in North America From Allergan, Inc. (NYSE: AGN) and Novavax, Inc. (Nasdaq: NVAX)
6. Novavax Enters Into Estrasorb(R) Asset Sale and Supply Agreements with Graceway Pharmaceuticals, LLC
7. Boehringer Ingelheim Pharmaceuticals, Inc. Receives the NCQA Seal Of Approval
8. Onyx Pharmaceuticals Announces a Teleconference and Webcast to Provide an Update on Nexavar and Report Full Year 2007 Financial Results
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. Keryx Biopharmaceuticals Announces Additions to Management Team
11. Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... PMG Research, Inc. announced today the formation of ... sites that provide clinical research services to pharmaceutical companies and ... its partnerships with large physician practices and integrated health systems. ... the Southeastern United States and spans over 60 physician practices. ... will be held by: Dr. Robert Holmes, MD, of PMG ...
(Date:11/26/2014)... November 25, 2014 The Pittcon marketing ... official conference and exposition mobile app, ... download in the App Store for iOS and Android ... resource tool before, during and after the event. It ... on exhibiting companies, technical sessions, Conferee Networking sessions and ...
(Date:11/26/2014)... 26, 2014 2014 Deep Research ... in-depth research report on the Global Palmitic Acid ... Palmitic Acid, basic information, including definition, classification, application, ... news analysis, etc. , For international and ... Acid market in China and other countries ...
(Date:11/24/2014)...  IGI Laboratories, Inc. (NYSE MKT: IG), a ... company, today announced it has submitted an additional abbreviated ... Drug Administration (FDA), which brings the Company,s total number ... submissions now pending at the FDA. ... Company, commented, "Our team here at IGI has continued ...
Breaking Biology Technology:PMG Research Names Medical Advisory Board 2PMG Research Names Medical Advisory Board 3Pittcon Releases 2015 Mobile App 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 2Palmitic Acid Industry Global 2014 Analysis & 2020 Forecasts on Market data, Statics, Development Now at ReportsnReports.com 3IGI Laboratories, Inc. Announces ANDA Submission 2
... , CLEVELAND , ... Cleveland Plus Region announces that between 2005 and 2009, $1.1 billion ... unique companies in the region. In the last five years, these 183 ... state of Ohio,s 2009 ranking as a top ten state ...
... detect broken bones, tumors and dental cavities, analyze atoms in ... knew they could cause crystals to form? A team ... the formation of a new type of crystal: charged cylindrical ... which is unknown in crystals. Similar phenomena may occur naturally ...
... SHANDONG , China , Jan. ... or the "Company") (OTC Bulletin Board:,CYIG) today announced that on ... the People,s Republic of China approved the patent,application ... unique method of making ginkgo tea, and the manufacturing,technology." This ...
Cached Biology Technology:$1.1 Billion Invested in 183 Companies in the Cleveland Plus(TM) Region in the Past Five Years 2$1.1 Billion Invested in 183 Companies in the Cleveland Plus(TM) Region in the Past Five Years 3$1.1 Billion Invested in 183 Companies in the Cleveland Plus(TM) Region in the Past Five Years 4$1.1 Billion Invested in 183 Companies in the Cleveland Plus(TM) Region in the Past Five Years 5$1.1 Billion Invested in 183 Companies in the Cleveland Plus(TM) Region in the Past Five Years 6$1.1 Billion Invested in 183 Companies in the Cleveland Plus(TM) Region in the Past Five Years 7Surprising discovery: X-rays drive formation of new crystals 2China YCT International Group, Inc. Announces That the State Intellectual Property Office of the People's Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd. 2China YCT International Group, Inc. Announces That the State Intellectual Property Office of the People's Republic of China has Approved a Patent to its Operating Subsidiary, Shandong Spring Pharmaceutical Co. Ltd. 3
(Date:11/21/2014)... , Nov. 20, 2014 Strict laws ... efficiency are piloting the North American and European automotive ... accidents growing, gesture recognition systems that are intuitive and ... mark in the industry. New analysis ... Gesture Recognition Market in Europe ...
(Date:11/18/2014)... -- The Parenteral Drug Association (PDA) today confirmed that seven ... at least seven more will participate in the upcoming 2014 ... in Washington D.C. , Dec. 2-4. ... from the regulatory agencies in the United States ... effort to help advance the use of metrics in the ...
(Date:11/10/2014)... shelves in early 2010, and people have used them ... be tossed into a washing machine without ever having ... though, has come with risks for young children. , ... found that from 2012 through 2013, U.S. poison control ... years of age swallowing, inhaling, or otherwise being exposed ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Study finds laundry detergent pods, serious poisoning risk for children 2
... Elsevier is pleased to announce that eight of ... annual BMA Medical Book Competition ceremony in London on ... highly commended and five received commendation. In total, 640 ... prizes awarded with 23 first prizes, 63 highly commended ...
... received a grant in excess of $2 million from the ... ideal time to fly that minimizes health complications to injured ... battlefield into a safe zone. "There is a ... cleaner, safer environment," explains Col. Warren Dorlac, MD, co-principal investigator ...
... available in French and Spanish . ... and the San Cecilio Teaching Hospital (Granada) have determined for ... corneal oedema and have identified the genes which cause it. ... and the San Cecilio University Hospital, who has recently ...
Cached Biology News:Elsevier congratulates its British Medical Association Award winning medical authors and editors 2US Air Force grant targets medical evacuation procedures 2US Air Force grant targets medical evacuation procedures 3US Air Force grant targets medical evacuation procedures 4Scientists identify the genes that cause blindness produced by corneal edema 2
Designed for flow cytometric applications intended to identify...
MOUSE ANTI RAT RT1Bu / MOUSE Ia:BIOTIN Immunogen: Rat thymocyte membrane glycoproteins...
MOUSE ANTI GUINEA PIG T-CELLS (PAN):FITC Immunogen: Guinea pig peritoneal T-cells...
MOUSE ANTI RABBIT T LYMPHOCTYES Immunogen: Rabbit Thymocytes...
Biology Products: